ADAR1 Capital Management, LLC
10% ownerADAR1 Capital Management, LLC (10% owner) filed 9 Form 4 reports as a reporting entity in the trailing twelve months (9 purchases, 0 sales), most often in Rallybio Corporation (RLYB). Across 6 priced purchase filings, the average 21-session return was +9.6% from execution and +15.9% from disclosure (delay-adjusted; derived). The largest single filing was $2.1M of RLYB (152,005 sh across 2 lots, as filed), executed May 4.
Add to watchlistMedian ADV $8.3M across their filed names
33% of their measured filings could not be priced (delisted or unquoted names). The returns above cover only what still trades.
Compounded across filings from disclosure dates · past 12 months
Open performance→Shares × price, as filed · by filing month · past 24 months
Sector per market data · by filing · past 12 months
900,000 sh × $1.78
Exec Sep 3
Filed Sep 8 · 5:16 PM ET TENXPURCHASE Tenax Therapeutics, Inc. View filing → $1.4M
770,333 sh across 3 lots
Exec Aug 31
Filed Sep 2 · 5:52 PM ET TENXPURCHASE Tenax Therapeutics, Inc. View filing → $1.8M
1,025,867 sh across 3 lots
Exec Aug 20
Filed Aug 24 · 6:12 PM ET NXTCPURCHASE NextCure, Inc. View filing → $1.6M
317,850 sh across 7 lots
Exec Jul 30
Filed Aug 3 · 5:53 PM ET INMPURCHASE InMed Pharmaceuticals Inc. View filing → $722K
468,551 sh across 3 lots
Exec May 19
Filed May 21 · 5:08 PM ET RLYBPURCHASE Rallybio Corporation View filing → $140K
10,000 sh × $13.98
Exec May 19
Filed May 20 · 8:45 PM ET RLYBPURCHASE Rallybio Corporation View filing → $1.1M
75,178 sh × $14.00
Exec May 13
Filed May 15 · 8:49 PM ET RLYBPURCHASE Rallybio Corporation View filing → $629K
44,900 sh across 2 lots
Exec May 11
Filed May 13 · 9:22 PM ET More filings →